303 related articles for article (PubMed ID: 15172861)
1. Changes in the utilization of prenatal diagnosis.
Benn PA; Egan JF; Fang M; Smith-Bindman R
Obstet Gynecol; 2004 Jun; 103(6):1255-60. PubMed ID: 15172861
[TBL] [Abstract][Full Text] [Related]
2. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
Nakata N; Wang Y; Bhatt S
Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
[TBL] [Abstract][Full Text] [Related]
3. Prenatal cytogenetic diagnosis in Spain: analysis and evaluation of the results obtained from amniotic fluid samples during the last decade.
Mademont-Soler I; Morales C; Clusellas N; Soler A; Sánchez A;
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):156-60. PubMed ID: 21492994
[TBL] [Abstract][Full Text] [Related]
4. Prenatal cytogenetic diagnosis study of 2782 cases of high-risk pregnant women.
Zhang L; Zhang XH; Liang MY; Ren MH
Chin Med J (Engl); 2010 Feb; 123(4):423-30. PubMed ID: 20193481
[TBL] [Abstract][Full Text] [Related]
5. Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000-2009.
Lichtenbelt KD; Alizadeh BZ; Scheffer PG; Stoutenbeek P; Schielen PC; Page-Christiaens LC; Schuring-Blom GH
Prenat Diagn; 2011 Aug; 31(8):765-72. PubMed ID: 21692084
[TBL] [Abstract][Full Text] [Related]
6. [Prenatal diagnosis].
Miny P; Tercanli S; Gänshirt D; Holzgreve W
Ther Umsch; 1995 Dec; 52(12):792-800. PubMed ID: 8539649
[TBL] [Abstract][Full Text] [Related]
7. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
8. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
[TBL] [Abstract][Full Text] [Related]
9. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
10. Utilization of amniocentesis and chorionic villus sampling by South Carolina women 35 years of age and older.
Knutson C; Young SR; Wade RV; Best RG
J S C Med Assoc; 1989 Oct; 85(10):463-7. PubMed ID: 2811307
[TBL] [Abstract][Full Text] [Related]
11. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial.
Philip J; Silver RK; Wilson RD; Thom EA; Zachary JM; Mohide P; Mahoney MJ; Simpson JL; Platt LD; Pergament E; Hershey D; Filkins K; Johnson A; Shulman LP; Bang J; MacGregor S; Smith JR; Shaw D; Wapner RJ; Jackson LG;
Obstet Gynecol; 2004 Jun; 103(6):1164-73. PubMed ID: 15172848
[TBL] [Abstract][Full Text] [Related]
12. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
[TBL] [Abstract][Full Text] [Related]
13. [Results of prenatal cytogenetic screening at the Prenatal Genetic Center of the Postgraduate Medical University between 1980-1990].
Tóth A; Hajdu K; Intödy Z; Rajczy K; László J
Orv Hetil; 1992 Jan; 133(2):71-5. PubMed ID: 1732882
[TBL] [Abstract][Full Text] [Related]
14. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
15. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping.
Cederholm M; Haglund B; Axelsson O
BJOG; 2003 Apr; 110(4):392-9. PubMed ID: 12699801
[TBL] [Abstract][Full Text] [Related]
16. Nuchal translucency screening: how do women actually utilize the results?
Caughey AB; Musci TJ; Belluomini J; Main D; Otto C; Goldberg J
Prenat Diagn; 2007 Feb; 27(2):119-23. PubMed ID: 17152116
[TBL] [Abstract][Full Text] [Related]
17. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
18. Health behaviour modelling for prenatal diagnosis in Australia: a geodemographic framework for health service utilisation and policy development.
Muggli EE; McCloskey D; Halliday JL
BMC Health Serv Res; 2006 Sep; 6():109. PubMed ID: 16945156
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of trisomy 21: registration results from a single genetic center.
Witters I; Fryns JP
Genet Couns; 2008; 19(2):157-63. PubMed ID: 18618989
[TBL] [Abstract][Full Text] [Related]
20. Prenatal cytogenetic diagnosis--a current audit. A review of 2000 cases of prenatal cytogenetic diagnoses after amniocentesis, and comparisons with early experience.
Bell JA; Pearn JH; Wilson BH; Ansford AJ
Med J Aust; 1987 Jan; 146(1):12-5. PubMed ID: 3796389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
